Kids Disease Child Disease Encyclopedia
Illustration representing Neonatal Jaundice (Hyperbilirubinemia)
Moderate Neonatal Pulmonary & Metabolic Dysfunctions

Neonatal Jaundice (Hyperbilirubinemia)

Neonatal Bilirubin Metabolic Clearance Dysfunction

Primary risk age: Neonates (Common in the first week of life; affects up to 60% of term and 80% of preterm infants)

Urgency
Moderate
Typical age
Neonates (Common in the first week of life; affects up to 60% of term and 80% of preterm infants)
Body system
Neonatal (Newborns)

Typical course: Physiological jaundice peaks on day 3-5 and resolves by day 7-10; breast milk jaundice can persist for 3 to 12 weeks.

Reviewed against AAP · CDC · WHO · NHS guidance Last reviewed 2026-06-13

1. Summary & Pathophysiology

Neonatal Bilirubin Metabolic Clearance Dysfunction

Pathophysiology (Development Path)

Bilirubin is produced by the breakdown of senescent red blood cells. Newborns have high red cell volume and short red cell lifespans. The newborn's liver cannot conjugate this massive load of unconjugated (indirect) bilirubin for excretion. Unconjugated bilirubin is lipid-soluble and can cross the blood-brain barrier.

Primary Causes & Etiology

Physiological: immature liver enzyme (UGT1A1) and high red cell mass. Pathological: ABO/Rh blood group incompatibility, G6PD deficiency, or breast milk jaundice.

2. Symptom Continuum

  1. Early Onset Signs

    Yellow discoloration of the sclera (white of the eyes) and face, typically appearing on day 2 or 3 of life.

  2. Progressive Phase

    The yellow tint spreads downward (cephalocaudal progression) to the chest, abdomen, and extremities as bilirubin levels rise.

  3. Severe Indicators

    Acute Bilirubin Encephalopathy (Kernicterus): marked by extreme lethargy, poor feeding (difficulty sucking), high-pitched crying, hypotonia transitioning to hypertonia (arching of the back/opisthotonos), and seizures.

3. Clinical Verification

Transcutaneous bilirubin (TcB) screening. Confirmed by measuring Total Serum Bilirubin (TSB) levels. Direct Coombs test to check for maternal antibody coating.

4. Care & Elements Plan

Primary Care Treatment Plan

Determine risk using hour-specific bilirubin nomograms. Initiate Phototherapy (exposure to blue-green light that photo-isomerizes bilirubin into water-soluble lumirubin for excretion). Ensure frequent feedings. Exchange transfusion for critical levels.

Home Support Elements

Feed the newborn frequently (every 2-3 hours) to promote bowel movements, which clears bilirubin. Monitor the number of wet and dirty diapers. Place the baby near a window for indirect sunlight if levels are borderline (under clinical guidance).

Generic Active Ingredients (No Brands)

  • None. No primary medications are used. Phototherapy is the standard treatment
  • intravenous immunoglobulin (IVIG) may be used in severe hemolytic disease.

Lists active elements only. Never administer self-designed therapies.

5. Doctor Critical Lines

Critical Thresholds: When to See a Doctor

Seek pediatric evaluation if jaundice appears in the first 24 hours of life, if the yellow color reaches the baby's abdomen or legs, or if the baby is lethargic and feeding poorly.

6. Vaccine & Prevention

Routine Prophylaxis (Prevention)

Ensure successful initiation of breastfeeding with 8-12 feedings daily. Check maternal blood type and Rh status during pregnancy.

Immunization Context

No specific immunizations are associated with this metabolic clearance dysfunction.

7. Timelines & Outlook

Active Timeline

Physiological jaundice peaks on day 3-5 and resolves by day 7-10; breast milk jaundice can persist for 3 to 12 weeks.

Expected Prognosis

Excellent. Phototherapy is highly effective and prevents brain damage. Kernicterus is extremely rare with modern screening protocols.

Potential Untreated Complications

Kernicterus (permanent brain damage causing athetoid cerebral palsy, hearing loss, and dental defects) if bilirubin levels rise unchecked.

More in Neonatal Pulmonary & Metabolic Dysfunctions

Emergency

Neonatal Respiratory Distress Syndrome (RDS)

Neonatal Surfactant Deficiency Pulmonary Disease

Premature Neonates (Incidence increases with decreasing gestational age; rare in term infants)

Emergency

Persistent Pulmonary Hypertension of the Newborn (PPHN)

Neonatal Severe Right-to-Left Shunt Hypoxemia

Term or near-term neonates (onset within hours of birth)

Emergency

Intraventricular Hemorrhage (IVH) of the Newborn

Neonatal Germinal Matrix Capillary Rupture Syndrome

Premature neonates (typically born before 32 weeks gestation or birth weight <1500g)